[Thrombotic thrombocytopenic purpura: the need of an early treatment].
García Castaño J, Pinilla Llorente B, García Román Jm, Rollán Landeras A, Sánchez Sánchez E, Gilsanz Fernández C
Abstract
García Castaño J, Pinilla Llorente B, García Román Jm, Rollán Landeras A, Sánchez Sánchez E, Gilsanz Fernández C
Abstract
Two patients affected by thrombotic thrombocytopenic purpura (TTP) are treated with plasmapheresis, fresh frozen plasma infusion, steroid and inhibitors of platelet aggregation with an impaired final stage: the first patient died during a plasmapheresis session and the other had a good evolution, obtaining complete recovery, maintained a year later. We discuss the clinical features and highlight the needs for early treatment with all the latest therapies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Two patients affected by thrombotic thrombocytopenic purpura (TTP) are treated with plasmapheresis, fresh frozen plasma infusion, steroid and inhibitors of platelet aggregation with an impaired final stage: the first patient died during a plasmapheresis session and the other had a good evolution, obtaining complete recovery, maintained a year later. We discuss the clinical features and highlight the needs for early treatment with all the latest therapies.
Key concepts: Plasmapheresis, Medicine, Thrombotic thrombocytopenic purpura, Fresh frozen plasma, Session (web analytics), Purpura (gastropod), Platelet, Surgery